RemeCare “M1 approved” by mHealthBelgium

16 August 2019

RemeCare Oncology was one of the first four mHealth apps included in the validation pyramid of mHealthBelgium. This approval means that this health application RemeCare Oncology has taken a first step towards a potential reimbursement when using this mobile application to guide cancer patients with their medication intake and monitor possible side effects during their chemotherapy.

This first step means that the government acknowledges that Remedus does have a CE certificate for the software as a medical device and that Remedus complies with the applicable GDPR legislation. The decision on a final reimbursement will follow in a further phase as you can read here.

Share

Recent news

Read our latest news

RemeCare “M1 approved” by mHealthBelgium

Global

16 August 2019

RemeCare “M1 approved” by mHealthBelgium

RemeCare Oncology was one of the first four mHealth apps included in the validation pyramid of mHealthBelgium. This approval means…

Read more
RemeCare Candidate Prix Galien 2018

Global

29 May 2019

RemeCare Candidate Prix Galien 2018

RemeCare (consisting of a web platform and smartphone application) is intended for use outside the hospital and allows caregivers to…

Read more
Remecare-App validated as medical trusted app

Global

01 May 2019

Remecare-App validated as medical trusted app

After years of development work and medical trials, Remedus is proud to announce that its RemeCare mobile health app has…

Read more